Issuance of Stock Acquisition Rights
First written in FY2017-Q2. 17 of 18 entries say "Advanced", first in FY2018-Q2. Latest entry: 2026-07-24.
- FY2026-H1AdvancedAnnual report
「Date of resolution 7 July 2025 Eligible recipients and number of recipients Directors of the company: 10 Executive officers of the company: 7 Number of share options * 500 Class, details and number of shares underlying the share options * 50,000 common shares Exercise price * ¥861 per share Exercise period * 25 July 2027 to 30 June 2034」
The company issued 500 share options and 50,000 common shares pursuant to the resolution of 7 July 2025, for 10 directors and 7 executive officers, and set an exercise period from 25 July 2027 to 30 June 2034. - FY2025-H1AdvancedAnnual report
「Date of resolution 8 July 2024 Eligible recipients and number of recipients Directors of the company: 9 Executive officers of the company: 8 Number of share options * 500 Class, details and number of shares underlying the share options * 50,000 common shares Exercise price * ¥969 per share Exercise period * 25 July 2026 to 30 June 2033」
The company issued 500 share options and 50,000 common shares pursuant to the resolution of 8 July 2024, for 9 directors and 8 executive officers, and set an exercise period from 25 July 2026 to 30 June 2033. - FY2024AdvancedAnnual report
「Date of resolution 25 June 2024 Eligible recipients and number of recipients Directors of the company: 9 Executive officers of the company: 8 Number of share options * Up to 500 Class, details and number of shares underlying the share options * Up to 50,000 common shares Exercise period * 25 July 2026 to 30 June 2033」
The company established a framework pursuant to the resolution of 25 June 2024, capped at 500 share options and 50,000 common shares for directors and executive officers, with an exercise period from 25 July 2026 to 30 June 2033. - FY2024-Q2AdvancedAnnual report
「Date of resolution 7 July 2023 Eligible recipients and number of recipients Directors of the company: 9 Executive officers of the company: 7 Number of share options * 500 (Note 1) Class, details and number of shares underlying the share options * 50,000 common shares Exercise price * ¥1,217 per share (Note 2) Exercise period * 25 July 2025 to 30 June 2032」
The company issued 500 share options and 50,000 common shares pursuant to the resolution of 7 July 2023, for 9 directors and 7 executive officers, and set an exercise period from 25 July 2025 to 30 June 2032. - FY2023AdvancedAnnual report
「Date of resolution: 27 June 2023 Eligible recipients and number of recipients: 9 directors of the company; 7 executive officers of the company Number of share options *: up to 500 Class, details and number of shares underlying the share options *: up to 50,000 common shares」
The company established a framework pursuant to the resolution of 27 June 2023, capped at 500 share options and 50,000 common shares for directors and executive officers. - FY2023-Q2AdvancedAnnual report
「Date of resolution 8 July 2022 Eligible recipients and number of recipients Directors of the company: 8 Executive officers of the company: 8 Number of share options * 260 (Note 1) Class, details and number of shares underlying the share options * 26,000 common shares Exercise price * ¥1,232 per share (Note 2) Exercise period * 23 July 2024 to 30 June 2031」
The company issued 260 share options and 26,000 common shares pursuant to the resolution of 8 July 2022, for 8 directors and 8 executive officers, with an exercise period from 23 July 2024 to 30 June 2031. - FY2022AdvancedAnnual report
「24 June 2022 Directors of the company: 8 Executive officers of the company: 8 Number of share options Up to 260 Class, details and number of shares underlying the share options Common shares Up to 26,000 shares」
The company established a framework, pursuant to the resolution of the annual general meeting of shareholders held on 24 June 2022, capped at 260 share options and 26,000 common shares for directors and executive officers. - FY2022-Q2AdvancedAnnual report
「Date of resolution 9 July 2021 Eligible recipients and number of recipients Directors of the company: 9 Executive officers of the company: 8 Number of share options * 130 (Note 1) Class, details and number of shares underlying the share options * 13,000 common shares Exercise price * ¥1,343 per share (Note 2) Exercise period * 22 July 2023 to 30 June 2030」
The company issued 130 share options and 13,000 common shares pursuant to the resolution of 9 July 2021, for 9 directors and 8 executive officers. - FY2021-Q2AdvancedAnnual report
「Date of resolution 10 July 2020 Eligible recipients and number of recipients Directors of the company: 8 Executive officers of the company: 9 Number of share options * 200 (Note 1) Class, details and number of shares underlying the share options * 20,000 common shares Exercise price * ¥1,215 per share (Note 2) Exercise period * 23 July 2022 to 30 June 2029」
The company issued 200 share options and 20,000 common shares pursuant to the resolution of 10 July 2020, for 8 directors and 9 executive officers, with an exercise period from 23 July 2022 to 30 June 2029. - FY2020-Q2AdvancedAnnual report
「Date of resolution: 12 July 2019 Eligible recipients and number of recipients: 8 directors of the company; 9 executive officers of the company Number of share options *: 300 (Note 1) Class, details and number of shares underlying the share options *: 30,000 common shares Exercise period *: 23 July 2021 to 30 June 2028」
The company issued 300 share options and 30,000 common shares pursuant to the resolution of 12 July 2019, for directors and executive officers. - FY2019AdvancedAnnual report
「Date of resolution: 26 June 2019 Eligible recipients and number of recipients: 8 directors of the company; 9 executive officers of the company Number of share options *: up to 300 Class, details and number of shares underlying the share options *: up to 30,000 common shares」
The company disclosed an issuance framework pursuant to the resolution of 26 June 2019, covering directors and executive officers and capped at 300 share options and 30,000 common shares. - FY2019-Q2AdvancedAnnual report
「The share options issued during the second quarter accounting period were as follows. Date of resolution 13 July 2018 Eligible recipients and number of recipients Directors of the company: 8 Executive officers of the company: 7 Number of share options * 500 (Note 1) Class, details and number of shares underlying the share options * 50,000 common shares Exercise price * ¥1,516 per share (Note 2) Exercise period * 21 July 2020 to 30 June 2027」
The company issued 500 share options, representing 50,000 underlying shares, pursuant to the resolution of 13 July 2018, and set an exercise period from 21 July 2020 to 30 June 2027. - FY2018-Q2AdvancedAnnual report
「Date of resolution 13 July 2017 Number of share options 400 (Note 1) Number of shares underlying the share options 400,000 common shares Exercise price ¥303 per share (Note 2) Exercise period 21 July 2019 to 30 June 2026」
The company newly disclosed 400 share options, representing 400,000 underlying shares, pursuant to the resolution of 13 July 2017, providing details including the exercise period. - FY2017-Q2First statedAnnual report
「The share options issued during the second quarter accounting period were as follows. Date of resolution: 15 July 2016 Number of share options: 500 (Note 1) Number of shares underlying the share options: 500,000 common shares Exercise price: ¥245 per share (Note 2) Exercise period: 20 July 2018 to 30 June 2025」
The company issued 500 share options, representing 500,000 underlying shares, pursuant to the resolution of 15 July 2016, with an exercise period from 20 July 2018 to 30 June 2025.